Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

Figure 2

Molecular probe platforms. Targeted contrast agents being developed for optical imaging include (A) small molecule, (B) peptide, (C) affibody, (D) activatable, (E) lectin, and (F) antibody. (G) Clinical studies are being performed using each platform in a wide range of cancers.